Literature DB >> 32040195

Disparities of National Lung Cancer Screening Guidelines in the US Population.

Summer S Han1,2,3, Eric Chow1, Kevin Ten Haaf4, Iakovos Toumazis5,6, Pianpian Cao7, Mehrad Bastani5,6, Martin Tammemagi8, Jihyoun Jeon7, Eric J Feuer9, Rafael Meza7, Sylvia K Plevritis2,5,6.   

Abstract

BACKGROUND: Current US Preventive Services Task Force (USPSTF) lung cancer screening guidelines are based on smoking history and age (55-80 years). These guidelines may miss those at higher risk, even at lower exposures of smoking or younger ages, because of other risk factors such as race, family history, or comorbidity. In this study, we characterized the demographic and clinical profiles of those selected by risk-based screening criteria but were missed by USPSTF guidelines in younger (50-54 years) and older (71-80 years) age groups.
METHODS: We used data from the National Health Interview Survey, the CISNET Smoking History Generator, and results of logistic prediction models to simulate lifetime lung cancer risk-factor data for 100 000 individuals in the 1950-1960 birth cohorts. We calculated age-specific 6-year lung cancer risk for each individual from ages 50 to 90 years using the PLCOm2012 model and evaluated age-specific screening eligibility by USPSTF guidelines and by risk-based criteria (varying thresholds between 1.3% and 2.5%).
RESULTS: In the 1950 birth cohort, 5.4% would have been ineligible for screening by USPSTF criteria in their younger ages but eligible based on risk-based criteria. Similarly, 10.4% of the cohort would be ineligible for screening by USPSTF in older ages. Notably, high proportions of blacks were ineligible for screening by USPSTF criteria at younger (15.6%) and older (14.2%) ages, which were statistically significantly greater than those of whites (4.8% and 10.8%, respectively; P < .001). Similar results were observed with other risk thresholds and for the 1960 cohort.
CONCLUSIONS: Further consideration is needed to incorporate comprehensive risk factors, including race and ethnicity, into lung cancer screening to reduce potential racial disparities.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 32040195      PMCID: PMC7669226          DOI: 10.1093/jnci/djaa013

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  25 in total

1.  Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking.

Authors:  Chien-Ching Li; Alicia K Matthews; Mantle M Rywant; Emily Hallgren; Raj C Shah
Journal:  Cancer Causes Control       Date:  2018-10-30       Impact factor: 2.506

2.  Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.

Authors:  Paul F Pinsky; Barnett S Kramer
Journal:  J Natl Cancer Inst       Date:  2015-10-19       Impact factor: 13.506

3.  Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

Authors:  Martin M Oken; Willam G Hocking; Paul A Kvale; Gerald L Andriole; Saundra S Buys; Timothy R Church; E David Crawford; Mona N Fouad; Claudine Isaacs; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Joshua M Rathmell; Thomas L Riley; Patrick Wright; Neil Caparaso; Ping Hu; Grant Izmirlian; Paul F Pinsky; Philip C Prorok; Barnett S Kramer; Anthony B Miller; John K Gohagan; Christine D Berg
Journal:  JAMA       Date:  2011-10-26       Impact factor: 56.272

4.  Lung carcinoma in African Americans and whites. A population-based study in metropolitan Detroit, Michigan.

Authors:  A G Schwartz; G M Swanson
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

5.  Potential Racial Disparities Using Current Lung Cancer Screening Guidelines.

Authors:  Srinadh Annangi; Snigdha Nutalapati; Marilyn G Foreman; Rathi Pillai; Eric L Flenaugh
Journal:  J Racial Ethn Health Disparities       Date:  2018-05-04

6.  Chapter 4: Development of the counterfactual smoking histories used to assess the effects of tobacco control.

Authors:  Theodore R Holford; Lauren Clark
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

7.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

Authors:  Martin C Tammemagi; Heidi Schmidt; Simon Martel; Annette McWilliams; John R Goffin; Michael R Johnston; Garth Nicholas; Alain Tremblay; Rick Bhatia; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; David M Hwang; Francis Laberge; Michel Gingras; Sergio Pasian; Christian Couture; John R Mayo; Paola V Nasute Fauerbach; Sukhinder Atkar-Khattra; Stuart J Peacock; Sonya Cressman; Diana Ionescu; John C English; Richard J Finley; John Yee; Serge Puksa; Lori Stewart; Scott Tsai; Ehsan Haider; Colm Boylan; Jean-Claude Cutz; Daria Manos; Zhaolin Xu; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Harmanjatinder S Sekhon; Paul Burrowes; Paul MacEachern; Stefan Urbanski; Don D Sin; Wan C Tan; Natasha B Leighl; Frances A Shepherd; William K Evans; Ming-Sound Tsao; Stephen Lam
Journal:  Lancet Oncol       Date:  2017-10-18       Impact factor: 41.316

8.  Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

Authors:  Harry J de Koning; Rafael Meza; Sylvia K Plevritis; Kevin ten Haaf; Vidit N Munshi; Jihyoun Jeon; Saadet Ayca Erdogan; Chung Yin Kong; Summer S Han; Joost van Rosmalen; Sung Eun Choi; Paul F Pinsky; Amy Berrington de Gonzalez; Christine D Berg; William C Black; Martin C Tammemägi; William D Hazelton; Eric J Feuer; Pamela M McMahon
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

9.  Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Authors:  Martin C Tammemägi; Timothy R Church; William G Hocking; Gerard A Silvestri; Paul A Kvale; Thomas L Riley; John Commins; Christine D Berg
Journal:  PLoS Med       Date:  2014-12-02       Impact factor: 11.069

10.  A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies.

Authors:  Kevin Ten Haaf; Mehrad Bastani; Pianpian Cao; Jihyoun Jeon; Iakovos Toumazis; Summer S Han; Sylvia K Plevritis; Erik F Blom; Chung Yin Kong; Martin C Tammemägi; Eric J Feuer; Rafael Meza; Harry J de Koning
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

View more
  10 in total

1.  Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.

Authors:  Randi M Williams; Tengfei Li; George Luta; Min Qi Wang; Lucile Adams-Campbell; Rafael Meza; Martin C Tammemägi; Kathryn L Taylor
Journal:  Cancer       Date:  2022-02-24       Impact factor: 6.860

2.  Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines.

Authors:  Alexandra L Potter; Chi-Fu Jeffrey Yang; Kirsten M Woolpert; Thrusha Puttaraju; Kei Suzuki; Julie R Palmer
Journal:  JAMA Oncol       Date:  2022-01-01       Impact factor: 31.777

3.  Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.

Authors:  Iakovos Toumazis; Koen de Nijs; Pianpian Cao; Mehrad Bastani; Vidit Munshi; Kevin Ten Haaf; Jihyoun Jeon; G Scott Gazelle; Eric J Feuer; Harry J de Koning; Rafael Meza; Chung Yin Kong; Summer S Han; Sylvia K Plevritis
Journal:  JAMA Oncol       Date:  2021-12-01       Impact factor: 33.006

4.  Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.

Authors:  Jacqueline V Aredo; Eunji Choi; Victoria Y Ding; Martin C Tammemägi; Kevin Ten Haaf; Sophia J Luo; Neal D Freedman; Lynne R Wilkens; Loïc Le Marchand; Heather A Wakelee; Rafael Meza; Sung-Shim Lani Park; Iona Cheng; Summer S Han
Journal:  JNCI Cancer Spectr       Date:  2022-05-02

5.  Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review.

Authors:  Ernesto Sosa; Gail D'Souza; Aamna Akhtar; Melissa Sur; Kyra Love; Jeanette Duffels; Dan J Raz; Jae Y Kim; Virginia Sun; Loretta Erhunmwunsee
Journal:  CA Cancer J Clin       Date:  2021-05-20       Impact factor: 286.130

6.  Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.

Authors:  Paul F Pinsky; Yan Kwan Lau; Chyke A Doubeni
Journal:  Chest       Date:  2021-02-03       Impact factor: 10.262

7.  Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.

Authors:  Rafael Meza; Jihyoun Jeon; Iakovos Toumazis; Kevin Ten Haaf; Pianpian Cao; Mehrad Bastani; Summer S Han; Erik F Blom; Daniel E Jonas; Eric J Feuer; Sylvia K Plevritis; Harry J de Koning; Chung Yin Kong
Journal:  JAMA       Date:  2021-03-09       Impact factor: 157.335

Review 8.  Implementation of lung cancer screening: what are the main issues?

Authors:  Carlijn M van der Aalst; Kevin Ten Haaf; Harry J de Koning
Journal:  Transl Lung Cancer Res       Date:  2021-02

9.  Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort.

Authors:  Raymond U Osarogiagbon; Wei Liao; Nicholas R Faris; Meghan Meadows-Taylor; Carrie Fehnel; Jordan Lane; Sara C Williams; Anita A Patel; Olawale A Akinbobola; Alicia Pacheco; Amanda Epperson; Joy Luttrell; Denise McCoy; Laura McHugh; Raymond Signore; Anna M Bishop; Keith Tonkin; Robert Optican; Jeffrey Wright; Todd Robbins; Meredith A Ray; Matthew P Smeltzer
Journal:  J Clin Oncol       Date:  2022-03-08       Impact factor: 50.717

Review 10.  The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening.

Authors:  Samuel Castro; Ernesto Sosa; Vanessa Lozano; Aamna Akhtar; Kyra Love; Jeanette Duffels; Dan J Raz; Jae Y Kim; Virginia Sun; Loretta Erhunmwunsee
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 3.005

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.